Redox Regulated HIV Expression in Alveolar Macrophages08/15/2003 - 11/30/2008 (PI)
NIH/National Heart, Lung, and Blood Institute5 K08 HL73671 05
COVID-PACT A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patients09/14/2020 - 09/13/2023 (PI)
Brigham and Womens Hospital
ECU-COV-401: SOLIRIS® (eculizumab) for the Treatment of Participants with
Coronavirus Disease 2019 (COVID-19) – An Expanded Access Program for Hospital-based Emergency Treatment.06/16/2020 - 06/15/2023 (PI)
Alexion Pharmaceuticals
ALXN1210-COV-305: A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute R06/08/2020 - 06/07/2023 (PI)
Alexion Pharmaceuticals